<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="15727">Carnosine</z:chebi> is present in high concentrations in skeletal muscle where it contributes to acid buffering and functions also as a natural protector against oxidative and <z:chebi fb="1" ids="23019">carbonyl</z:chebi> stress </plain></SENT>
<SENT sid="1" pm="."><plain>Animal studies have shown an anti-diabetic effect of <z:chebi fb="0" ids="15727">carnosine</z:chebi> supplementation </plain></SENT>
<SENT sid="2" pm="."><plain>High carnosinase activity, the <z:chebi fb="0" ids="15727">carnosine</z:chebi> degrading enzyme in serum, is a risk factor for <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> in humans </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of the present study was to compare the muscle <z:chebi fb="0" ids="15727">carnosine</z:chebi> concentration in diabetic subjects to the level in non-diabetics </plain></SENT>
<SENT sid="4" pm="."><plain>Type 1 and 2 diabetic patients and matched healthy controls (total n=58) were included in the study </plain></SENT>
<SENT sid="5" pm="."><plain>Muscle <z:chebi fb="0" ids="15727">carnosine</z:chebi> content was evaluated by proton magnetic resonance spectroscopy (3 Tesla) in soleus and gastrocnemius </plain></SENT>
<SENT sid="6" pm="."><plain>Significantly lower <z:chebi fb="0" ids="15727">carnosine</z:chebi> content (-45%) in gastrocnemius muscle, but not in soleus, was shown in type 2 diabetic patients compared with controls </plain></SENT>
<SENT sid="7" pm="."><plain>No differences were observed in type 1 diabetic patients </plain></SENT>
<SENT sid="8" pm="."><plain>Type II diabetic patients display a reduced muscular <z:chebi fb="0" ids="15727">carnosine</z:chebi> content </plain></SENT>
<SENT sid="9" pm="."><plain>A reduction in muscle <z:chebi fb="0" ids="15727">carnosine</z:chebi> concentration may be partially associated with defective mechanisms against oxidative, glycative and <z:chebi fb="1" ids="23019">carbonyl</z:chebi> stress in muscle </plain></SENT>
</text></document>